Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).

Steven A. Kaplan,Sender Herschorn,Kevin T. McVary,David R. Staskin,Christopher R. Chapple,Steve Foley,Javier Cambronero Santos,Rita M. Kristy,Nurul Choudhury,John Hairston,Carol R. Schermer

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).

2020

Steven A. Kaplan
Sender Herschorn
Kevin T. McVary
David R. Staskin
Christopher R. Chapple
Steve Foley
Javier Cambronero Santos
Rita M. Kristy
Nurul Choudhury
John Hairston
Carol R. Schermer

Purpose:PLUS investigated the efficacy and safety of mirabegron add-on therapy in men with overactive bladder (OAB) symptoms receiving tamsulosin for underlying lower urinary tract symptoms attribu...

Keywords:

Lower urinary tract symptoms
Urology
Hyperplasia
Tamsulosin
Overactive bladder
Mirabegron
Medicine
Placebo
add on therapy
Urinary bladder

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations